# The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.

> **NCT01813565** · NA · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Interstitial Cystitis

## Interventions

- **DRUG:** Hyaluronic acid/chondroitin sulfate

## Key facts

- **NCT ID:** NCT01813565
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03-20
- **Primary completion:** 2016-12-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** No benefit of intravesical instillation of Hyaluronic Acid/Chondroitin Sulfate
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813565, "The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01813565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*